申请人:Cell Therapeutics, Inc.
公开号:US20040204386A1
公开(公告)日:2004-10-14
The invention relates to pyrimidines and uses thereof, including to inhibit lysophosphatidic acid acyltransferase &bgr; (LPAAT-&bgr;) activity and/or proliferation of cells such as tumor-cells.
这项发明涉及
嘧啶类化合物及其用途,包括抑制溶
磷脂酸酰基转移酶β(LP
AAT-β)活性和/或抑制肿瘤细胞等细胞的增殖。